Literature DB >> 14532982

Hypericin-mediated photodynamic therapy induces lipid peroxidation and necrosis in nasopharyngeal cancer.

Hong-Yan Du1, Malini Olivo, Benny Kwong-Huat Tan, Boon-Huat Bay.   

Abstract

Photoactivation of hypericin is known to generate singlet oxygen and superoxide anion radicals. Reactive oxygen species (ROS) produced by photodynamic therapy (PDT) has the capacity to induce oxidative damage and tumor destruction. We have previously shown that hypericin-PDT induces tumor shrinkage and regression in the human nasopharyngeal cancer (NPC)/HK1 murine tumor model. In this extended study, we show by electron microscopy that subcutaneously implanted HK1 NPC cells from Balb/c nude mice perished by cell necrosis with hypericin-PDT treatment. There was evidence of cytoplasmic swelling accompanied by loss of cell membrane integrity and autophagic vacuolization of cytoplasm but no nuclear changes. There was also no significant difference in the apoptotic index of control and PDT-treated tumors, when analyzed by in situ end labeling of DNA strand breakage to detect apoptosis. This further supports the observation that cell death in PDT-treated NPC/HK1 tumors was by necrosis. Lipid peroxidative stress analyzed by the malonaldehyde assay was significantly elevated in PDT-treated cells. However, PDT had no effect on the activity of superoxide dismutase, an intracellular antioxidant enzyme. The findings show that hypericin-PDT of nasopharyngeal tumors in vivo induces tumor necrosis with accompanying lipid peroxidation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532982

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  8 in total

1.  Phototoxicity in human retinal pigment epithelial cells promoted by hypericin, a component of St. John's wort.

Authors:  Albert R Wielgus; Colin F Chignell; David S Miller; Ben Van Houten; Joel Meyer; Dan-Ning Hu; Joan E Roberts
Journal:  Photochem Photobiol       Date:  2007 May-Jun       Impact factor: 3.421

2.  Efficacy of chlorin e6-mediated sono-photodynamic therapy on 4T1 cells.

Authors:  Qing Li; Xiaobing Wang; Pan Wang; Kun Zhang; Haiping Wang; Xiaolan Feng; Quanhong Liu
Journal:  Cancer Biother Radiopharm       Date:  2013-11-09       Impact factor: 3.099

3.  Neuroprotective effect of H. perforatum extracts on beta-amyloid-induced neurotoxicity.

Authors:  Bruno A Silva; Alberto C P Dias; Federico Ferreres; João O Malva; Catarina R Oliveira
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

4.  Retinal nitric oxide and malonyldialdehyde levels following photodynamic therapy.

Authors:  Peykan Turkuoglu; Cem Ozturkmen; Nevin Ilhan; Julide Kurt; Orhan Aydemir; Ulku Celiker; Mohamed A Ibrahim; Aymen Rashid
Journal:  Indian J Ophthalmol       Date:  2011 Jan-Feb       Impact factor: 1.848

Review 5.  Enhanced radiation sensitivity and radiation recall dermatitis (RRD) after hypericin therapy -- case report and review of literature.

Authors:  Kurt Putnik; Peter Stadler; Christof Schäfer; Oliver Koelbl
Journal:  Radiat Oncol       Date:  2006-09-01       Impact factor: 3.481

6.  Apogossypolone targets mitochondria and light enhances its anticancer activity by stimulating generation of singlet oxygen and reactive oxygen species.

Authors:  Zhe-Yu Hu; Jing Wang; Gang Cheng; Xiao-Feng Zhu; Peng Huang; Dajun Yang; Yi-Xin Zeng
Journal:  Chin J Cancer       Date:  2011-01

7.  De Novo transcriptome assembly (NGS) of Curcuma longa L. rhizome reveals novel transcripts related to anticancer and antimalarial terpenoids.

Authors:  Ramasamy S Annadurai; Ramprasad Neethiraj; Vasanthan Jayakumar; Anand C Damodaran; Sudha Narayana Rao; Mohan A V S K Katta; Sreeja Gopinathan; Santosh Prasad Sarma; Vanitha Senthilkumar; Vidya Niranjan; Ashok Gopinath; Raja C Mugasimangalam
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

Review 8.  Hypericin in the Light and in the Dark: Two Sides of the Same Coin.

Authors:  Zuzana Jendželovská; Rastislav Jendželovský; Barbora Kuchárová; Peter Fedoročko
Journal:  Front Plant Sci       Date:  2016-05-06       Impact factor: 5.753

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.